Abstract: The present invention relates to pharmaceutically acceptable compounds, including certain substituted indolinyl and derivatives thereof, 1,2,3,4-tetrahydroquinolinyl and derivatives thereof, 1,2,3,4-tetrahydroisoquinolinyl, benz[cd]indolinyl and 5,6-dihydrophenanthridinyl compounds, and methods of treatment and pharmaceutical compositions that utilize or comprise one or more such compounds. Compounds of the invention are particularly useful for the treatment or prophylaxis of neurological injury and neurodegenerative disorders.
Type:
Grant
Filed:
November 9, 2001
Date of Patent:
February 4, 2003
Assignee:
Scion Pharmaceuticals, Inc.
Inventors:
N. Laxma Reddy, Michael Maillard, David Berlove, Sharad Magar, Graham J. Durant